Hedussin (Dry Extract Of Hederae Folium (Der 4-8:1), Extracting Agent: Ethanol 30 % (M/M))

Hedussin is primarily marketed as a herbal extract of ivy leaf; at present, no specific medical indications have been formally approved, and its use is generally aligned with traditional applications of Hederae folium.

• Traditional use as a respiratory herbal supplement.
• Inclusion in phytotherapeutic formulations for expectorant purposes.
• Potential role in supporting mucosal health of the upper airway.
• Used as a component in over‑the‑counter herbal cough mixtures.
• Investigated in some studies for anti‑inflammatory activity of leaf constituents.
• Employed in topical preparations for soothing minor skin irritation.

The safety profile of Hedussin reflects that of typical ivy leaf extracts; most reported effects are mild and reversible, while rare serious reactions have been documented.

Common

• Mild gastrointestinal discomfort such as nausea or stomach upset.
• Transient headache.
• Skin redness or mild rash at the site of contact.
• Dizziness or light‑headedness.
• Dry mouth.
• Taste disturbance.

Serious

• Severe allergic reaction (anaphylaxis).
• Persistent vomiting or diarrhea.
• Significant bronchospasm in sensitive individuals.
• Hepatic enzyme elevation (rare).
• Acute liver injury.
• Cardiovascular effects such as hypotension.

When considering Hedussin, several precautionary measures should be observed to minimize risk, especially for individuals with pre‑existing conditions or those taking other medications.

• Avoid use in persons with known hypersensitivity to ivy or related plants.
• Exercise caution in patients with asthma or chronic obstructive pulmonary disease.
• Do not use during pregnancy or lactation unless advised by a healthcare professional.
• Monitor liver function in patients with existing hepatic disease.
• Keep out of reach of children.
• Discontinue use and seek medical attention if signs of an allergic reaction appear.

Herbal extracts can interact with conventional medicines; the following potential interactions have been reported for ivy leaf constituents.

Avoid

• Concurrent use with potent bronchodilators may increase risk of bronchospasm.
• Combination with anticoagulant or antiplatelet agents could enhance bleeding tendency.

Use with caution

• May affect metabolism of drugs processed by CYP450 enzymes; monitor levels of such medications.
• May potentiate the effects of other cough suppressants; adjust dosing accordingly.
• Co‑administration with diuretics may increase electrolyte disturbances.